HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Philip J Gold Selected Research
Philip J Gold Research Topics
Disease
9
Neoplasms (Cancer)
11/2023 - 10/2009
4
Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 09/2006
4
Adenocarcinoma
01/2023 - 09/2010
2
Colonic Neoplasms (Colon Cancer)
10/2022 - 01/2019
2
Cholangiocarcinoma
08/2012 - 12/2011
2
Esophageal Neoplasms (Esophageal Cancer)
05/2012 - 09/2010
1
Breast Neoplasms (Breast Cancer)
02/2024
1
Microsatellite Instability
10/2022
1
Peripheral Nervous System Diseases (PNS Diseases)
10/2022
1
Turcot syndrome
10/2022
1
Hepatocellular Carcinoma (Hepatoma)
02/2013
1
Venous Thromboembolism
08/2012
1
Carcinoma (Carcinomatosis)
08/2012
1
Diarrhea
02/2012
1
Anorexia
02/2012
1
Exanthema (Rash)
02/2012
1
Fatigue
02/2012
1
Nausea
02/2012
1
Vomiting
02/2012
1
Gallbladder Neoplasms (Gallbladder Cancer)
12/2011
1
Pathologic Complete Response
12/2011
1
Heart Diseases (Heart Disease)
10/2009
Drug/Important Bio-Agent (IBA)
3
pembrolizumab
IBA
11/2023 - 01/2020
3
Oxaliplatin (Eloxatin)
FDA Link
Generic
10/2022 - 12/2011
3
Capecitabine (Xeloda)
FDA Link
10/2022 - 09/2006
2
Trastuzumab (Herceptin)
FDA Link
01/2023 - 01/2020
2
margetuximab
IBA
01/2023 - 01/2020
2
Tyrosine Kinase Inhibitors
IBA
10/2022 - 02/2012
2
Fluorouracil (Carac)
FDA Link
Generic
10/2022 - 12/2011
2
Irinotecan (Camptosar)
FDA Link
Generic
05/2012 - 09/2006
2
Cetuximab (Erbitux)
FDA Link
05/2012 - 09/2010
1
Sunitinib (Sutent)
FDA Link
02/2024
1
Nivolumab
IBA
09/2023
1
Ipilimumab
IBA
09/2023
1
Circulating Tumor DNA
IBA
01/2023
1
Biomarkers (Surrogate Marker)
IBA
01/2023
1
regorafenib
IBA
10/2022
1
cabozantinib
IBA
10/2022
1
Leucovorin (Folinic Acid)
FDA Link
10/2022
1
Monoclonal Antibodies
IBA
01/2020
1
codrituzumab
IBA
02/2013
1
Glypicans
IBA
02/2013
1
Alkaline Phosphatase
IBA
08/2012
1
Bilirubin
IBA
08/2012
1
Sorafenib (BAY 43-9006)
FDA Link
08/2012
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
08/2012
1
Cisplatin (Platino)
FDA Link
Generic
05/2012
1
Adenosine Triphosphate (ATP)
IBA
02/2012
1
Phosphotransferases (Kinase)
IBA
02/2012
1
bosutinib
IBA
02/2012
1
Gemcitabine
FDA Link
12/2011
1
Messenger RNA (mRNA)
IBA
12/2011
1
ErbB Receptors (EGF Receptor)
IBA
09/2010
1
romidepsin (FK228)
FDA Link
10/2009
1
Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)
IBA
09/2006
1
Thymidylate Synthase
IBA
09/2006
1
Thymidine Phosphorylase
IBA
09/2006
Therapy/Procedure
7
Therapeutics
01/2023 - 09/2006
4
Drug Therapy (Chemotherapy)
10/2022 - 10/2009
2
Adjuvant Chemotherapy
10/2022 - 01/2019
2
Radiotherapy
05/2012 - 12/2011
1
Duration of Therapy
01/2019
1
Neoadjuvant Therapy
12/2011